syndrome also known hemangioma rare disease usually infants vascular tumor leads decreased platelet counts sometimes bleeding also known hemangioma thrombocytopenia syndrome named haig haigouni kasabach katharine krom merritt two pediatricians first described condition initially vascular lesion usually noted skin firm hard indurated areas tiny red dots petechiae appear around lesion parts body vascular lesion internal petechiae bruising seen skin bruising spontaneous bleeding also occur tumors hemangiomas usually present young infants less three months age also reported toddler age group tumors occur extremities chest neck abdomen pelvis infiltrate across tissue aggravated interventions infection trauma tumors associated kmp internal chest abdomen cause significant illness lifethreatening due bleeding internal lesions take longer time diagnose syndrome usually caused hemangioendothelioma vascular tumor often present although tumors relatively common rarely cause syndromecitation needed tumors large growing rapidly sometimes trap platelets causing severe thrombocytopenia combination vascular tumor consumptive thrombocytopenia defines syndrome tumors found trunk upper lower extremities retroperitoneum cervical facial consumptive coagulopathy also uses clotting factors fibrinogen may worsen bleeding coagulopathy progress disseminated intravascular coagulation even hemolytic anemia secondary microangiopathic destruction physical damage rbcs expressed mild moderate diagnostic directed presenting signs symptoms involve patients uniformly show severe thrombocytopenia low fibrinogen levels high fibrin degradation products due fibrinolysis microangiopathic management syndrome particularly severe cases complex require joint effort multiple subspecialists rare disease consensus treatment guidelines large randomized controlled trials guide therapycitation needed patient syndrome extremely ill may need intensive care risk bleeding complications including intracranial hemorrhage thrombocytopenia coagulopathy managed platelet transfusions fresh frozen plasma although caution needed due risk fluid overload heart failure multiple transfusions possibility disseminated intravascular coagulation dangerous difficulttomanage condition concerning anticoagulant antiplatelet medications used careful assessment risks generally treatment underlying vascular tumor results resolution syndrome complete surgical resection feasible provides good opportunity cure although dangerous operate vascular tumor patient prone bleeding even appropriate surgical subspecialists surgery possible various used control tumor syndrome mortality rate patients survive acute disease supportive care may required gradual recoverycitation neededfurthermore patients may need care dermatologist plastic surgeon residual cosmetic lesions otolaryngologist head neckairway involvement longterm followup patients skin discoloration andor mild disfiguration dormant